0.82 USD
▼-0.01-1.71%
盘后 0.80 -2.57%
2026-09-15
市值
$105.38M
市盈率
—
EPS
-0.22
股息率
—
52 周区间
0.45 – 3.87
成交量
733.97K
Beta
0.70
目标价
7.20
52W 低 0.4552W 高 3.87
价格走势
公司简介
Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and drugs orally for patients, physicians, and healthcare systems with a alternative to painful injections in the United States. The company develops the RaniPill capsule, a drug-agnostic oral delivery platform to deliver a variety of drug substances, including oligonucleotides, peptides, proteins, and antibodies. Its product pipeline includes RT-105, an anti-TNF-alpha antibody that is in prec...